No Detail Found!

Prevention of doxorubicin-associated cardiac toxicity by metformin, vitamin E, and carvedilol: A comparative study

Author(s)
Khalida Ajmal Department of Pharmacology & Therapeutics, Wah Medical College,Wah Cantt,Pakistan
Ayesha Afzal Department of Pharmacology & Therapeutics, Wah Medical College,Wah Cantt,Pakistan
Saima Rafique Department of Pharmacology & Therapeutics, Wah Medical College,Wah Cantt,Pakistan
Abeera Sikandar Department of Pharmacology & Therapeutics, Wah Medical College,Wah Cantt,Pakistan
Zahid Mahmood Department of Pharmacology & Therapeutics, Wah Medical College,Wah Cantt,Pakistan
Ayman Zafar Department of Pharmacology & Therapeutics, Wah Medical College,Wah Cantt,Pakistan
Abstract
Objective: To compare evading effects of alpha tocopherol, carvedilol, and metformin on early detection of myocardial damage caused by doxorubicin. Methodology: This randomized in-vivo study in rabbits was performed from Oct 2021 to March 2022 at Department of Pharmacology & Therapeutics, Wah Medical College. A cohort of 30 healthy albino male adult rabbits were used. Cardiotoxicity was induced in one group by injecting doxorubicin whereas the control group was administered 0.9% saline. The pretreatment of the other three experimental groups was carried out with alpha tocopherol, carvedilol, and metformin for 11 days prior to doxorubicin injection. Blood sampling was taken on the 12th day for biomarkers and slides of heart sections were made for microscopic examination. Results: Doxorubicin caused marked myocardial damage portrayed by elevation of serum biomarkers levels like cTnI, CK-MB and LDH, and severe necrosis of cardiac cells. Concurrent treatment with a-tocopherol, carvedilol and metformin led to reduced serum levels of these biomarkers with improved histopathological images, more obvious in carvedilol and metformin groups. Conclusion: The use of carvedilol, metformin, and a-tocopherol can mitigate cardiac adverse effects doxorubicin. The quantitative estimation of serum cTnI may prove cost-effective by identifying extent of cardiac injury at subclinical stage.
Publication Details
Page(s) 669-672
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
lactate dehydrogenase, Doxorubicin, Cardiac Troponin I, LDH, creatine kinase-MB.
References
Johnson-Arbor K,Dubey R,Island (FL): StatPearls Publishing R .2023 .. , : .
Henriksen PA .2018 .Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention. Heart, 104 : 971-7.
Ajmal K,Ajmal M,Afzal A,Saima A,Naeem U,Sikandar A .2019 .Comparison of protective effects of carvedilol and atocopherol on doxorubicin-induced cardiotoxicity. IJBCP, 8 : 1944-50.
Anusha V,Sandur VR,Khan S. .2020 .A review of chemical tools for induction of cardiotoxicity. Drug Invention Today, 14 : 370-5.
Attina G,Triarico S,Romano A,Maurizi P,Mastrangelo S,Ruggiero A .2022 .Serum biomarkers for the detection of cardiac dysfunction in childhood cancers receiving anthracycline-based treatment. BJP, 15 : 1311-21.
Cai F,Luis MA,Lin X,Wang M,Cai L,Cen C .2019 .Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review). Mol Clin Oncol, 11 : 15-23.
Proskuriakova E,Jada K,Kakieu Djossi S,Khedr A,Neupane B .2021 .Mechanisms and Potential Treatment Options of Heart Failure in Patients with Multiple Myeloma. Cureus, 13 : e15943.
de Oliveira VA,Monteiro Fernandes AN,dos Santos Leal LM,Ferreira Lima PA,Silva Pereira AR,Pereira IC .2023 .α-tocopherol as a selective modulator of toxicogenic damage induced by antineoplastic agents' cyclophosphamide and doxorubicin. JTEHS, 86 : 87-102.
Ahmad R,Hasan IH,Mahmoud AM .2020 .Liposomal resveratrol and/or carvedilol attenuate doxorubicininduced cardiotoxicity by modulating inflammation, oxidative stress and S100A1 in rats. Antioxidants, 9 : 159-64.
Zhan TD,Daniyal MD,Li JD,Mao YD .2020 .Preventive use of carvedilol for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. Herz, 45 : 1-4.
Jung-Min Yu,Mao-Chih Hsieh,Szu-Yuan Wu Hsieh .2019 .Metformin reduces radiation-induced cardiac toxicity risk in patients having breast cancer. Am J Cancer Res, 9 : 1017-26.
Ajzashokouhi A,Bostan H,Jomezadeh V,Hayes A,Karimi G. .2020 .A review on the cardioprotective mechanisms of metformin against doxorubicin. HET, 39 : 237-48.
Gava FN,Zacché E,Ortiz EM,Champion T,Bandarra MB,Vasconcelos RO .2013 .Doxorubicin induced dilated cardiomyopathy in a rabbit model: An update. Res Vet Sci, 94 : 115-21.
Che FF,Liu Y,Xu CG .2010 .Schisandrin B prevents doxorubicin-induced cardiotoxicity in rabbits. J Sinhuan Univ, 41 : 24-6.
Cardinale D,Iacopo F,Cipolla CM .2020 .. Cardiotoxicity of Anthracyclines. Front Cardiovasc Med, 7 : 3-5.
Sawyer DB,Zuppinger C,Miller TA,Eppenberger HM,Suter TM .2002 .Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity. Circulation, 105 : 1551-4.
Attina G,Triarico S,Romano A,Maurizi P,Mastrangelo S,Ruggiero A .2022 .Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment. Biomed Pharmacol J, 15 : .
Howlader N,Noone AM,Krapcho M,Miller D,Brest A,Yu M .2019 .. SEER Cancer Statistics Rev, : 1975-2016.
Moustafa I,Saka S,Viljoen M,Oosthuizen F. Vitamin E .2022 .and levocarnitine as prophylaxis against doxorubicininduced cardio toxicity in the adult cancer patient: A review. JOPP, 28 : 1388-99.
Milei J,Boveris A,Llesuy S. .1986 .Amelioration of adriamycininduced cardiotoxicity in rabbits by prenylamine and vitamins A and E. Am Heart J, 111 : 95-102.
Zhang QL,Yang JJ,Zhang HS .2019 .Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy. Biomed Pharmacother, 109 : 71-83.
Xuan H. Hu Di,Ren Lei,Yang Lei .2019 .The cardioprotective effects of carvedilol on ischemia and reperfusion injury by AMPK signaling pathway. Biomed Pharmacother, 117 : 109106.
Mustafa A,Kazım Ü,Mehmet F.S Ü,Abdullah Ö .2016 .of metformin against doxorubicin cardiotoxicity in rats. Anatol J Cardiol, 16 : 234-41.
0

Citations

0

Downloads

50

Views